Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05880836 · ClinicalTrials.gov registry record · NA
In Line Aerosol Nebulization With High Flow
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT05880836 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 40 participants.
The verdict
NCT05880836, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The objective of ILAN is to assess the safety, feasibility and bronchodilator efficacy of in-line bronchodilator nebulizer delivery with VMN via HFNC system in hypoxemic respiratory failure patients treated with bronchodilators and compare this method to standard-nebulization using a jet nebulizer with a facial mask. The investigators hypothesized that aerosol nebulization using HFNC/VMN represents safer and more convenient approach in hypoxemic respiratory failure patients in comparison to conventional therapy while providing similar bronchodilator efficacy.
Interventions
- DEVICE nebulizer via in-line drug delivery maintaining high-flow nasal cannula oxygen
- DEVICE standard jet nebulization (SJN) with face mask
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2025-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05880836
The ClinicalTrials.gov registry entry for NCT05880836 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which nebulizer via in-line drug delivery maintaining high-flow nasal cannula oxygen is the first listed.
NCT05880836 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05880836 about?
NCT05880836 is a clinical study titled "In Line Aerosol Nebulization With High Flow". The objective of ILAN is to assess the safety, feasibility and bronchodilator efficacy of in-line bronchodilator nebulizer delivery with VMN via HFNC system in hypoxemic respiratory failure patients treated with bronchodilators and compare this method to standard-nebulization using a jet nebulizer w...
What is the current status of trial NCT05880836?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2023-09-01. Estimated completion is 2025-01-01.
What interventions are being tested in trial NCT05880836?
The interventions under investigation include: nebulizer via in-line drug delivery maintaining high-flow nasal cannula oxygen (DEVICE), standard jet nebulization (SJN) with face mask (DEVICE).
Who is sponsoring clinical trial NCT05880836?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.